GeneVec’s Pancreatic Cancer Therapy Crashes – Corante (blog)

GeneVec's Pancreatic Cancer Therapy Crashes
Corante (blog)
Another promising Phase II oncology idea goes into the trench in Phase III: GenVec has been working on a gene-therapy approach ("TNFerade") to induce
GenVec shares implode on pancreatic cancer trial failureFierceBiotech
GenVec says cancer drug not effective, ends trialReuters
GenVec shares crater on failed drug studyMarketWatch
Reuters
all 85 news articles »

Post to Twitter Tweet This Post